Clinical and molecular aspects of frontotemporal dementia

Neurodegenerative Diseases

Volumn 1, Issue 4-5, 2004, Pages 218-224

  Froelich Fabre, Susanne ^a,b   Skoglund, Lena ^a   Ostojic, Jovanka ^a   Kilander, Lena ^a   Lindau, Maria ^a   Glaser, Anna ^a   Basun, Hans ^a,b   Lannfelt, Lars ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Clinical features; Frontotemporal lobe dementia; Genetic aspects; Neurofibrillary inclusions; Tau

Indexed keywords

TAU PROTEIN; UBIQUITIN;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; APATHY; BEHAVIOR; BRAIN NERVE CELL; CHROMOSOME 17; CHROMOSOME 17Q; CHROMOSOME 3; CHROMOSOME 9; CLINICAL FEATURE; DEGENERATIVE DISEASE; DISABILITY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; EXON; FAMILIAL DISEASE; FRONTAL CORTEX; FRONTAL LOBE; FRONTOTEMPORAL DEMENTIA; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GLIOSIS; HEREDITY; HISTOPATHOLOGY; HUMAN; MISSENSE MUTATION; MOLECULAR BIOLOGY; MULTIINFARCT DEMENTIA; NEOCORTEX; NERVE DEGENERATION; NEUROFILAMENT; NEUROPATHOLOGY; NONHUMAN; PARKINSONISM; PATHOGENESIS; POPULATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SENILE PLAQUE; SEQUENCE ANALYSIS; STAINING; STRUCTURE ANALYSIS; TEMPORAL CORTEX; TEMPORAL LOBE;

DEMENTIA; HUMANS; INCLUSION BODIES; MUTATION; TAU PROTEINS;

EID: 9244248705     PISSN: 16602854     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080989     Document Type: Review

References (65)

1. Pick A: Über die Beziehungen der senilen Hirnatrophie zur Aphasie. Prag Med Wochenschr 1892;17:165-167.
2. Alzheimer A: Über eigenartige Krankheitsfälle des späteren Alters. Z Gesamte Neurol Psychiatr 1911;4:356-385.
3. Brun A, Englund B, Gustafson L, Mann DMA, Neary D, Snowden JS: Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416-418.
4. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF: Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
5. Snowden JS, Neary D, Mann DMA: Frontotemporal dementia. Br J Psychiatry 2002;180:140-143.
6. Mega MS, Cummings JL: Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci 1994;6:358-370.
7. Neary D, Snowden JS, Mann DMA: Classification and description of frontotemporal dementias. Ann N Y Acad Sci 2000;920:46-51.
8. Lindau M, Andersen C, Johansson S-E, Julin P, Blomberg M, Wahlund L-O, Almkvist O: Functional specialization or interaction in the frontal lobes: Volumetric measurements in relation to cognition and behavior in frontotemporal dementia. Alzheimers Rep 2001;4:45-53.
9. Neary D, Snowden J: Fronto-temporal dementia: Nosology, neuropsychology, and neuropathology. Brain Cogn 1996;31:176-187.
10. Mann DM, McDonagh AM, Snowden J, Neary D, Pickering-Brown SM: Molecular classification of the dementias. Lancet 2000;355:626.
11. Tolnay M, Probst A: Frontal lobe degeneration: Novel ubiquitin- immunoreactive neurites within frontotemporal cortex. Neuropathol Appl Neurobiol 1995;21:492-497.
12. Kertesz A, Kawarai T, Rogaeva E, St. George-Hyslop P, Poorkaaj P, Bird T, Munoz DG: Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions. Neurology 2000;54:818-827.
13. Bigio EH, Lipton AM, White CL 3rd, Dickson DW, Hirano A: Frontotemporal and motor neurone degeneration with neurofilament inclusion bodies: Additional evidence for overlap between FTD and ALS. Neuropathol Appl Neurobiol 2003;29:239-253.
14. Spillantini MG, Goedert M: Tau protein pathology in neurodegenerative disease. Trends Neurosci 1998;21:428-432.
15. Iqbal IG, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM: Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 1986;261:6084-6089.
16. Feany MB, Mattiace LA, Dickson DW: Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration. J Neuropathol Exp Neurol 1996;55:53-67.
17. Litvan I: The clinical and pathologic hallmarks of progressive supranuclear palsy. Curr Opin Neurol 1997;10:346-350.
18. Buee-Scherrer V, Buee L, Hof PR, Leveugle B, Gilles C, Loerzel AJ, Perl DP, Delacourte A: Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins. Am J Pathol 1995;146:924-932.
19. Ghetti B, Piccardo P, Spillantini MG, Ichimiya Y, Porro M, Perini F, Kitamoto T, Tateishi J, Seiler C, Frangione B, Bugiani O, Giaccone G, Prelli F, Goedert M, Dlouhy SR, Tagliavini F: Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: The phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci USA 1996;93:744-748.
20. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW: A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA 1975;72:1858-1862.
21. Ingelson M, Vanmechelen E, Lannfelt L: Microtubule-associated protein tau in human fibroblasts with the Swedish Alzheimer mutation. Neurosci Lett 1996;220:9-12.
22. Gu Y, Oyama F, Ihara Y: Tau is widely expressed in rat tissues. J Neurochem 1996;67:1235-1244.
23. Neve RL, Harris P, Kosik KS, Kurnit DM, Donlon TA: Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2. Brain Res 1986;387:271-280.
24. Andreadis A, Brown WM, Kosik KS: Structure and novel exons of the human τ gene. Biochemistry 1992;31:10626-10633.
25. Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA: Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 1989;3:519-526.
26. Lee G, Neve RL, Kosik KS: The microtubule binding domain of tau protein. Neuron 1989;2:1615-1624.
27. Mawal-Dewan M, Henley J, Van de Voorde A, Trojanowski JQ, Lee VM: The phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatases. J Biol Chem 1994;269:30981-30987.
28. Rosner H, Rebhan M, Vacun G, Vanmechelen E: Developmental expression of tau proteins in the chicken and rat brain: Rapid down-regulation of a paired helical filament epitope in the rat cerebral cortex coincides with the transition from immature to adult tau isoforms. Int J Dev Neurosci 1995;13:607-617.
29. Hanger DP, Betts JC, Loviny TL, Blackstock WP, Anderton BH: New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry. J Neurochem 1998;71:2465-2476.
30. Anderton BH, Betts J, Blackstock WP, Brion JP, Chapman S, Connell J, Dayanandan R, Gallo JM, Gibb G, Hanger DP, Hutton M, Kardalinou E, Leroy K, Lovestone S, Mack T, Reynolds CH, Van Slegtenhorst M: Sites of phosphorylation in tau and factors affecting their regulation. Biochem Soc Symp 2001;67:73-80.
31. Hagestedt T, Lichtenberg B, Wille H, Mandelkow EM, Mandelkow E: Tau protein becomes long and stiff upon phosphorylation: Correlation between paracrystalline structure and degree of phosphorylation. J Cell Biol 1989;109:1643-1651.
32. Gustafson L: Frontal lobe degeneration of non-Alzheimer type. 2. Clinical picture and differential diagnosis. Arch Gerontol Geriatr 1987;6:209-223.
33. Stevens M, van Duijn CM, Kamphorst W, de Knijff P, Heutink P, van Gool WA, Scheltens P, Ravid R, Oostra BA, Niermeijer MF, van Swieten JC: Familial aggregation in frontotemporal dementia. Neurology 1998;50:1541-1545.
34. Wilhelmsen KC, Lynch T, Pavlou E, Higgins M, Nygaard TG: Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. Am J Hum Genet 1994;55:1159-1165.
35. Foster NL, Wilhelmsen K, Sima AAF, Jones MZ, D'Amato CJ, Gilman S: Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference. Ann Neurol 1997;41:706-715.
36. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B: Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998;95:7737-7741.
37. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaff E, Wauters E, van Baren MJ, Hillebrand M, Joosse M, Kwon JM, Nowotny P, Kuei Che L, Norton J, Morris JC, Reed LA, Trojanowski J, Basun H, Lannfelt L, Neystat M, Fahn S, Dark F, Tannenberg T, Dodd PR, Hayward N, Kwok JBJ, Schofield PR, Andreadis A, Snowden J, Craufurd D, Neary D, Owen F, Oostra BA, Hardy J, Goate A, van Swieten J, Mann D, Lynch T, Heutink P: Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702-705.
38. Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L, Andreadis A, Widerholt WC, Raskind M, Schellenberg GD: Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998;43:815-825.
39. Clark LN, Poorkaj P, Wszolek Z, Geschwind DH, Nasreddine ZS, Miller B, Li D, Payami H, Awert F, Markopoulou K, Andreadis A, D'Souza I, Lee VM-Y, Reed L, Trojanowski JQ, Zhukareva V, Bird T, Schellenberg G, Wilhelmsen KC: Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci USA 1998;95:13103-13107.
40. Ingram EM, Spillantini MG: Tau gene mutations: Dissecting the pathogenesis of FTDP-17. Trends Mol Med 2002;8:555-562.
41. Reed LA, Wsolek ZB, Hutton M: Phenotypic correlations in FTDP-17. Neurobiol Ageing 2001;22:89-107.
42. Goode BL, Chau M, Denis PE, Feinstein SC: Structural and functional differences between 3-repeat and 4-repeat tau isoforms. J Biol Chem 2000;275:38182-38189.
43. von Bergen M, Barghorn S, Li L, Marx A, Biernat J, Mandelkow EM, Mandelkow E: Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure. J Biol Chem 2001;276:48165-48174.
44. Schneider JA, Watts RL, Gearing M, Brewer RP, Mirra SS: Corticobasal degeneration: Neuropathologic and clinical heterogeneity. Neurology 1997;48:959-969.
45. Conrad C, Andreadis A, Trojanowski JQ, Dickson DW, Kang D, Chen X, Wiederholt W, Hansen L, Masliah E, Thal LJ, Katzman R, Xia Y, Saitoh T: Genetic evidence for the involvement of τ in progressive supranuclear palsy. Ann Neurol 1997;41:277-281.
46. Di Maria E, Tabaton M, Vigo T, Abbruzzese G, Bellone E, Donati C, Frasson E, Marchese R, Montagna P, Munoz DG, Pramstaller PP, Zanusso G, Ajmar F, Mandich P: Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann Neurol 2000;47:374-377.
47. Spillantini MG, Yoshida H, Rizzini C, Lantos PL, Khan N, Rossor MN, Goedert M, Brown J: A novel tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies. Ann Neurol 2000;48:939-943.
48. Stanford PM, Halliday GM, Brooks WS, Kwok JB, Storey CE, Creasey H, Morris JG, Fulham MJ, Schofield PR: Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: Expansion of the disease phenotype caused by tau gene mutations. Brain 2000;123:880-893.
49. Poorkaj P, Muma NA, Zhukareva V, Cochran EJ, Shannon KM, Hurtig H, Koller WC, Bird TD, Trojanowski JQ, Lee VM, Schellenberg GD: An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype. Ann Neurol 2002;52:511-516.
50. Hayashi S, Toyoshima Y, Hasegawa M, Umeda Y, Wakabayashi K, Tokiguchi S, Iwatsubo T, Takahashi H: Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation. Ann Neurol 2002;51:525-530.
51. Ostojic J, Elfgren C, Passant U, Nilsson K, Gustafson L, Lannfelt L, Froelich Fabre S: The tau R406W mutation causes progressive presenile dementia with bitemporal atrophy. Dement Geriatr Cogn Disord 2004;17:298-301.
52. Rademakers R, Dermaut B, Peeters K, Cruts M, Heutink P, Goate A, Van Broeckhoven C: Tau (MAPT) mutation Arg406Trp presenting clinically with Alzheimer disease does not share a common founder in Western Europe. Hum Mutat 2003;22:409-411.
53. van Swieten JC, Stevens M, Rosso SM, Rizzu P, Joosse M, de Koning I, Kamphorst W, Ravid R, Spillantini MG, Niermeijer, Heutink P: Phenotypic variation in hereditary frontotemporal dementia with tau mutations. Ann Neurol 1999;46:617-626.
54. Schraen-Maschke S, Dhaenens CM, Delacourte A, Sablonniere B: Microtubule-associated protein tau gene: A risk factor in human neurodegenerative diseases. Neurobiol Dis 2004;15:449-460.
55. Froelich S, Basun H, Forsell C, Lilius L, Axelman K, Andreadis A, Lannfelt L: Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12-21. Am J Med Genet 1997;74:380-385.
56. Rosso SM, Kamphorst W, de Graaf B, Willemsen R, Ravid R, Niermeijer MF, Spillantini MG, Heutink P, Van Swieten JC: Familial frontotemporal dementia with ubiquitin-positive inclusions linked to chromosome 17q21-22. Brain 2001;124:1948-1957.
57. Rademakers R, Cruts M, Dermaut B, Sleegers K, Rosso SM, Van Den Broeck M, Backhovens H, Van Swieten J, Van Duijn CM, Van Broeckhoven C: Tau-negative frontal lobe dementia at 17q21: Significant finemapping of the candidate region to a 4.8-cm interval. Mol Psychiatry 2002;7:1064-1074.
58. Lendon CL, Lynch T, Norton J, McKeel DW, Busfield F, Craddock N, Chakraverty S, Gopalakrishnan G, Shears SD, Grimmett W, Wilhelmsen KC, Hansen L, Morris JC, Goate AM: Hereditary dysphasic disinhibition dementia: A frontotemporal dementia linked to 17q21-22. Neurology 1998;50:1546-1555.
59. Froelich Fabre S, Axelman P, Almkvist A, Basun H, Lannfelt L: Extended investigation of tau and mutation screening of other candidate genes on chromosome 17q21 in a Swedish FTDP-17 family. Am J Med Genet 2003;121B:112-118.
60. Brown J, Ashworth A, Gydesen S, Sorensen A, Rossor M, Hardy J, Collinge J: Familial nonspecific dementia maps to chromosome 3. Hum Mol Genet 1995;4:1625-1628.
61. Hosler BA, Siddique T, Sapp PC, Sailor W, Huang MC, Hossain A, Daube JR, Nance M, Fan C, Kaplan J, Hung WY, McKenna-Yasek D, Haines JL, Pericak-Vance MA, Horvitz HR, Brown RHJ: Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. JAMA 2000;284:1664-1669.
62. Ostojic J, Axelman K, Lannfelt L, Froelich-Fabre S: No evidence of linkage to chromosome 9q21-22 in a Swedish family with frontotemporal dementia and amyotrophic lateral sclerosis. Neurosci Lett 2003;340:245-247.
63. Poorkaj P, Grossman M, Steinbart E, Payami H, Sadovnick A, Nochlin D, Tabira T, Trojanowski JQ, Borson S, Galasko D, Reich S, Quinn B, Schellenberg G, Bird TD: Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. Arch Neurol 2001;58:383-387.
64. Houlden H, Baker M, Adamson J, Grover A, Waring S, Dickson D, Lynch T, Boeve B, Petersen RC, Pickering-Brown S, Owen F, Neary D, Craufurd D, Snowden J, Mann D, Hutton M: Frequency of tau mutations in three series of non-Alzheimer's degenerative dementia. Ann Neurol 1999;46:243-248.
65. Froelich Fabre S, Forsell C, Viitanen M, Sjögren M, Wallin A, Blomberg M, Andersen C, Wahlund L-O, Lannfelt L: Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau, high apolipoprotein E ε4 frequency, but no tau gene mutations. Exp Neurol 2001;168:413-418.